VANESSA RANDO: Open Payments
NPI 1770741761 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,732 in 121 payments from 19 companies in 2025. Trend: 2023 $2,123 · 2024 $2,780 · 2025 $2,732
Food & beverage: $2,548Education: $184
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $469 |
| Janssen Biotech, Inc. | 10 | $314 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $281 |
| Incyte Corporation | 10 | $267 |
| Arcutis Biotherapeutics, Inc. | 10 | $192 |
| Amgen Inc. | 6 | $166 |
| LEO Pharma Inc. | 6 | $164 |
| Galderma Laboratories, L.P. | 13 | $149 |
| Regeneron Healthcare Solutions, Inc. | 5 | $129 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
Products named: SKYRIZI, TREMFYA, OPZELURA, Zoryve, OTEZLA, DUPIXENT, RINVOQ, ILUMYA.
Industry payments across MA — which companies pay providers there.
